FOA
TEVA icon

Five Oceans Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Five Oceans Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$399K Buy
11,784
+1,226
+12% +$40.8K 0.13% 106
2026
Q1 		$318K Hold
10,558
– – 0.12% 110
2025
Q4 		$330K Buy
10,558
+186
+2% +$4.58K 0.12% 106
2025
Q3 		$210K Buy
10,372
+75
+0.7% +$1.32K 0.08% 175
2025
Q2 		$173K Buy
+10,297
New +$166K 0.07% 187
2025
Q1 		– Sell
-13,018
Closed -$287K – 190
2024
Q4 		$287K Sell
13,018
-1,457
-10% -$26.5K 0.13% 103
2024
Q3 		$261K Buy
14,475
+3,840
+36% +$67.2K 0.12% 143
2024
Q2 		$173K Buy
+10,635
New +$164K 0.09% 168

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Five Oceans Advisors's TEVA Position: Q2 2026 in Review

Five Oceans Advisors increased its Teva Pharmaceuticals (TEVA) stake by 12% in Q2 2026, buying an estimated $40.8K and bringing the position to 11,784 shares worth $399K. The position accounts for 0.13% of the portfolio, ranked #106.

Five Oceans Advisors first reported a position in TEVA in Q2 2024 and has held it in 8 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Five Oceans Advisors held 11,784 shares of Teva Pharmaceuticals worth $399K as of Q2 2026.
  • Five Oceans Advisors bought 1,226 Teva Pharmaceuticals shares in Q2 2026, an estimated $40.8K.
  • Teva Pharmaceuticals made up 0.13% of Five Oceans Advisors's portfolio in Q2 2026, its #106 holding.
  • Five Oceans Advisors first reported a position in Teva Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Five Oceans Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.